Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer 2022-03-01 08:48
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial 2022-03-01 05:01
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash 2022-02-28 22:15
ALPS PHARMA LAUNCHES A NEW QUERCETIN DELIVERY COMPOSITION 2022-02-28 09:19
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis 2022-02-28 08:00
JW Therapeutics Announces NMPA Acceptance of the Supplemental New Drug Application for Carteyva® in Patients with Relapsed or Refractory Follicular Lymphoma 2022-02-27 18:30
First patient treated in cohort 2 SARTATE™ neuroblastoma therapy trial 2022-02-25 22:04
Jean-Luc Herbeaux to become Hovione CEO 2022-02-25 22:00
Daewoong Pharmaceutical Announces Successful Phase 3 Topline Results for New Antidiabetic Drug's Triple Combination Therapy 2022-02-25 22:00
HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets 2022-02-25 10:00
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era 2022-02-24 20:00
CSR Committee: PQE Group establishes internal department to enhance charitable and volunteering projects' governance 2022-02-24 17:00
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer 2022-02-24 13:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China 2022-02-24 10:32
Alphamab Oncology Announced Publication of Clinical Results of KN026 in HER2-positive Breast Cancer in Clinical Cancer Research 2022-02-24 09:41
Innovent Announces First Patient Dosed with CD73 Antibody in Phase 1a/1b Clinical Trial for Advanced Solid Tumor 2022-02-24 08:00
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement 2022-02-23 23:00
Orpha Labs AG Announces the Initiation of a Phase III Trial Evaluating ORL-101 for Treatment of Leukocyte Adhesion Deficiency Type II 2022-02-23 21:27
SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension 2022-02-23 21:00
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma 2022-02-23 17:53
1 193 194 195 196 197 416